Logo image of CMBT.BR

CMB TECH NV (CMBT.BR) Stock Fundamental Analysis

EBR:CMBT - Euronext Brussels - BE0003816338 - Common Stock - Currency: EUR

10.67  -0.08 (-0.74%)

Fundamental Rating

6

Overall CMBT gets a fundamental rating of 6 out of 10. We evaluated CMBT against 62 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT has an excellent profitability rating, but there are some minor concerns on its financial health. CMBT may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make CMBT a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
In the past year CMBT had a positive cash flow from operations.
CMBT had positive earnings in 4 of the past 5 years.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M

1.2 Ratios

With an excellent Return On Assets value of 39.20%, CMBT belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
CMBT has a Return On Equity of 75.63%. This is amongst the best in the industry. CMBT outperforms 96.67% of its industry peers.
CMBT has a better Return On Invested Capital (19.79%) than 83.33% of its industry peers.
Industry RankSector Rank
ROA 39.2%
ROE 75.63%
ROIC 19.79%
ROA(3y)7.08%
ROA(5y)7.35%
ROE(3y)9.49%
ROE(5y)10.76%
ROIC(3y)N/A
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 83.69%, CMBT belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CMBT has grown nicely.
Looking at the Operating Margin, with a value of 46.80%, CMBT belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
CMBT's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 68.73%, CMBT is doing good in the industry, outperforming 73.33% of the companies in the same industry.
CMBT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 46.8%
PM (TTM) 83.69%
GM 68.73%
OM growth 3Y4.59%
OM growth 5YN/A
PM growth 3Y21.12%
PM growth 5YN/A
GM growth 3Y-0.85%
GM growth 5Y8.95%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CMBT is creating value.
The number of shares outstanding for CMBT has been increased compared to 1 year ago.
CMBT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CMBT has been reduced compared to a year ago.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.26 indicates that CMBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CMBT has a Altman-Z score of 2.26. This is in the better half of the industry: CMBT outperforms 63.33% of its industry peers.
CMBT has a debt to FCF ratio of 3.08. This is a good value and a sign of high solvency as CMBT would need 3.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.08, CMBT is in the better half of the industry, outperforming 68.33% of the companies in the same industry.
CMBT has a Debt/Equity ratio of 0.60. This is a neutral value indicating CMBT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.60, CMBT is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 3.08
Altman-Z 2.26
ROIC/WACC2.66
WACC7.44%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.33 indicates that CMBT should not have too much problems paying its short term obligations.
CMBT has a worse Current ratio (1.33) than 61.67% of its industry peers.
CMBT has a Quick Ratio of 1.28. This is a normal value and indicates that CMBT is financially healthy and should not expect problems in meeting its short term obligations.
CMBT's Quick ratio of 1.28 is in line compared to the rest of the industry. CMBT outperforms 55.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.28
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

5

3. Growth

3.1 Past

CMBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.29%, which is quite impressive.
Measured over the past years, CMBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.93% on average per year.
Looking at the last year, CMBT shows a very strong growth in Revenue. The Revenue has grown by 44.52%.
Measured over the past years, CMBT shows a quite strong growth in Revenue. The Revenue has been growing by 15.53% on average per year.
EPS 1Y (TTM)65.29%
EPS 3Y24.93%
EPS 5YN/A
EPS Q2Q%-68.42%
Revenue 1Y (TTM)44.52%
Revenue growth 3Y0.68%
Revenue growth 5Y15.53%
Sales Q2Q%-20.31%

3.2 Future

Based on estimates for the next years, CMBT will show a very negative growth in Earnings Per Share. The EPS will decrease by -23.24% on average per year.
Based on estimates for the next years, CMBT will show a small growth in Revenue. The Revenue will grow by 3.15% on average per year.
EPS Next Y-69.28%
EPS Next 2Y-41.59%
EPS Next 3Y-23.24%
EPS Next 5YN/A
Revenue Next Year-25.03%
Revenue Next 2Y-4.78%
Revenue Next 3Y3.15%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

7

4. Valuation

4.1 Price/Earnings Ratio

CMBT is valuated cheaply with a Price/Earnings ratio of 1.96.
Based on the Price/Earnings ratio, CMBT is valued cheaper than 95.00% of the companies in the same industry.
CMBT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.47.
A Price/Forward Earnings ratio of 7.57 indicates a rather cheap valuation of CMBT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMBT indicates a somewhat cheap valuation: CMBT is cheaper than 65.00% of the companies listed in the same industry.
CMBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE 1.96
Fwd PE 7.57
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CMBT's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CMBT is valued a bit cheaper than the industry average as 76.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.73
EV/EBITDA 3.43
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The excellent profitability rating of CMBT may justify a higher PE ratio.
A cheap valuation may be justified as CMBT's earnings are expected to decrease with -23.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.59%
EPS Next 3Y-23.24%

0

5. Dividend

5.1 Amount

No dividends for CMBT!.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

EBR:CMBT (2/5/2025, 2:01:06 PM)

10.67

-0.08 (-0.74%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-27 2025-02-27/amc
Inst Owners2.86%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.35B
Analysts80
Price Target16.01 (50.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend3.12
Dividend Growth(5Y)91.85%
DP43.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)312.39%
Min EPS beat(2)294.49%
Max EPS beat(2)330.29%
EPS beat(4)4
Avg EPS beat(4)163.02%
Min EPS beat(4)2.43%
Max EPS beat(4)330.29%
EPS beat(8)7
Avg EPS beat(8)99.9%
EPS beat(12)9
Avg EPS beat(12)68.55%
EPS beat(16)10
Avg EPS beat(16)47.36%
Revenue beat(2)1
Avg Revenue beat(2)44.49%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)90.95%
Revenue beat(4)3
Avg Revenue beat(4)50.82%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)112.13%
Revenue beat(8)7
Avg Revenue beat(8)54.41%
Revenue beat(12)11
Avg Revenue beat(12)56.3%
Revenue beat(16)15
Avg Revenue beat(16)61.11%
PT rev (1m)0.64%
PT rev (3m)-1.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.76%
EPS NY rev (3m)-10.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-2.78%
Revenue NY rev (3m)-3.62%
Valuation
Industry RankSector Rank
PE 1.96
Fwd PE 7.57
P/S 1.38
P/FCF 4.73
P/OCF 2.82
P/B 1.25
P/tB 1.26
EV/EBITDA 3.43
EPS(TTM)5.44
EY50.98%
EPS(NY)1.41
Fwd EY13.21%
FCF(TTM)2.26
FCFY21.16%
OCF(TTM)3.78
OCFY35.46%
SpS7.71
BVpS8.54
TBVpS8.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 39.2%
ROE 75.63%
ROCE 26.38%
ROIC 19.79%
ROICexc 23.66%
ROICexgc 23.82%
OM 46.8%
PM (TTM) 83.69%
GM 68.73%
FCFM 29.27%
ROA(3y)7.08%
ROA(5y)7.35%
ROE(3y)9.49%
ROE(5y)10.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y14.99%
ROICexcg growth 5YN/A
ROICexc growth 3Y14.77%
ROICexc growth 5YN/A
OM growth 3Y4.59%
OM growth 5YN/A
PM growth 3Y21.12%
PM growth 5YN/A
GM growth 3Y-0.85%
GM growth 5Y8.95%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 3.08
Debt/EBITDA 1.14
Cap/Depr 169.32%
Cap/Sales 19.79%
Interest Coverage 7.2
Cash Conversion 83.89%
Profit Quality 34.97%
Current Ratio 1.33
Quick Ratio 1.28
Altman-Z 2.26
F-Score6
WACC7.44%
ROIC/WACC2.66
Cap/Depr(3y)171.91%
Cap/Depr(5y)117.72%
Cap/Sales(3y)63.03%
Cap/Sales(5y)41.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.29%
EPS 3Y24.93%
EPS 5YN/A
EPS Q2Q%-68.42%
EPS Next Y-69.28%
EPS Next 2Y-41.59%
EPS Next 3Y-23.24%
EPS Next 5YN/A
Revenue 1Y (TTM)44.52%
Revenue growth 3Y0.68%
Revenue growth 5Y15.53%
Sales Q2Q%-20.31%
Revenue Next Year-25.03%
Revenue Next 2Y-4.78%
Revenue Next 3Y3.15%
Revenue Next 5YN/A
EBIT growth 1Y95.73%
EBIT growth 3Y5.3%
EBIT growth 5YN/A
EBIT Next Year-24.44%
EBIT Next 3Y5.58%
EBIT Next 5YN/A
FCF growth 1Y239.23%
FCF growth 3Y-12.5%
FCF growth 5YN/A
OCF growth 1Y816.22%
OCF growth 3Y-4.78%
OCF growth 5Y297.76%